Results · Apr-Jun 2026 · filed 14 Aug 2026
Gennex Laboratories Q1 FY27 results
Sales grew 17% to ₹39.8 crore from ₹34.2 crore in Apr-Jun 2025.
Operating profit fell 14% to ₹4.4 crore, an operating margin of 11.0% (down 3.9 points from a year ago).
Net profit fell 7% to ₹4.7 crore from ₹5 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −35%, net profit +5%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 39.8 | 34.2 | +17% |
| Operating profit (EBITDA) | 4.4 | 5.1 | −14% |
| Operating margin | 11.0% | 14.8% | −3.9 pts |
| Net profit | 4.7 | 5.0 | −7% |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 17 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 14 Aug 2026Un-Audited Financial Results For The Quarter Ended June 30, 2026
- 14 Aug 2026Board Meeting Outcome for Un-Audited Financial Results For The Quarter Ended June 30, 2026
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.